Skip to main content
Fig. 3 | Arthritis Research & Therapy

Fig. 3

From: Differential long-term retention of biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis by age group from the FIRST registry

Fig. 3

Changes in CDAI in adjusted data using inverse probability of treatment weighting. Changes in CDAI in all patients (a), patients aged < 65 years (b), patients aged 65–74 years (c), and patients aged ≥ 75 years (d). Data are presented as mean ± 95% confidence interval (error bars). CDAI = clinical disease activity index; yr = years; TNFi = tumor necrosis factor inhibitors; ABA = abatacept; TCZ = tocilizumab

Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us